HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

Continuous Glucose Monitoring


Endocrine Month in Review: November 2022

November 26, 2022

The November 2022 endocrine month in review features coverage of the FDA’s approval of teplizumab, new data related to use of GLP-1 receptor agonists, and a trio of stories on topics pertaining to diabetes technology.

Black Patients Less Likely to be Prescribed, Have Discussions around CGMs, Insulin Pumps

November 24, 2022

A Johns Hopkins-led analysis provides a snapshot of trends in racial disparities seen in both uptake of and engagement in discussions with providers around continuous glucose monitoring and insulin pumps among adults with type 1 diabetes.

FDA Issues Recall for Insulet Devices for Battery, Overheating Issues that Could Cause Fire

November 17, 2022

Announced on November 17, the US FDA Class I recall for the Insulet Omnipod DASH Insulin Management System Personal Diabetes Manager comes after the company had received more than 450 complaints related to battery swelling, fluid leakage from battery, and extreme overheating, including 3 instances that included fires.

Flash Monitoring Could Prove Useful for Glucose Monitoring in Hemodialysis, Regardless of Diabetes Status

November 15, 2022

A 15-person study comparing flash monitoring to standard self-monitoring in people on hemodialysis with or without diabetes provides clinicians and researchers with insight into the potential clinical applicability of these devices in similar patient populations.

Study Finds Dexcom G7 Setup is Easier, Requires Fewer Tasks for Older Adults than Previous Generations

November 10, 2022

A formal task analysis conducted in older adults with type 2 diabetes provides insight into the ease of use and task burden associated with uptake of the Dexcom G7 CGM system, with results indicating use of the system required fewer than half as many steps to initiate as previous generations of the CGM system.

Endocrine Month in Review: October 2022

October 29, 2022

The October 2022 month in review recap includes a pair of studies that paint a grim picture related to the burden of diabetes in the US, a trio of new obesity guidelines/reports from major national and international organizations, and news related to the latest developments in the world of continuous glucose monitoring.

Increased Scanning Frequency Improves Glucose Control, Hypoglycemia Fear in T1D Using CGM

October 28, 2022

An analysis of patient data from people with type 1 diabetes using flash glucose monitoring suggests increased scanning frequency could improve glycemic control and reduce fear of hypoglycemia in people using intermittently scanned continuous glucose monitoring.

Diabetes Dialogue: EASD 2022 and CGM News

October 13, 2022

In this special edition episode of Diabetes Dialogue, our hosts break down their top clinical takeaways from the European Association for the Study of Diabetes 2022 annual meeting, new data from the FLASH-UK trial, the global launch of Dexcom G7, and the announcement of US availability for the FreeStyle Libre 3.